← All trials
NCT05661240
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2022
- Primary completion
- May 25, 2024
- Completion date
- Jul 31, 2025
- First posted
- Dec 22, 2022
- Last posted
- Dec 22, 2022
- Enrollment
- 348
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou Pharmaceucal Company LimitedLead sponsor
- Albert Einstein Israelite HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.